Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2 | Nature Communications
SARS-CoV-2-Variante Omikron – Wikipedia
Omikron ist das Schreckgespenst - doch die Mutante kann die Pandemie beenden - FOCUS online
Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions
Omikron: Italien drängt zu europaweiten Beschränkungen
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic - ScienceDirect
Omicron is a Multiply Recombinant Set of Variants That Have Evolved Over Many Months - SARS-CoV-2 Molecular Evolution - Virological
Neuer Omikron-Subtyp auf dem Vormarsch | Max Delbrück Center
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein - Kumar - 2022 - Journal of Medical Virology - Wiley Online Library
Siemens Healthineers SARS-CoV-2 Testing Portfolio Detects Omicron Variant
RKI - Coronavirus SARS-CoV-2 - Hilfestellung zur Ableitung variantenspezifischer PCR-Testungen aus charakteristischen Aminosäure-Austauschen und Deletionen bei SARS-CoV-2
SARS-CoV-2-Variante Omikron – Wikipedia
How Ominous Is the Omicron Variant (B.1.1.529)?
Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen
Omikron PCR Test zur Bestimmung von der Omikron Variante
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization | Nature
Omicron (BA.2) variant | Expression vectors | InvivoGen
Viruses | Free Full-Text | A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Sanger Sequencing for SARS-CoV-2 Omicron Variant Surveillance
Omicron: How do I know if I have it? - BBC News
How to extract the spike sequence of the omicron variant from uploaded samples at GISAID? - Bay-VOC
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles | PNAS
